Sky Century Investment (SKYI) Change in Accured Expenses (2012 - 2026)
Sky Century Investment (SKYI) posted quarterly Change in Accured Expenses of -$68265.0 for Q2 2026, down 210.38% year-over-year from $61847.0 in Q2 2025, and down 817.17% quarter-over-quarter from -$7443.0 in Q1 2026.
Sky Century Investment (SKYI) Change in Accured Expenses (2012 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has reported Change in Accured Expenses for 6 consecutive years, with -$68265.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Change in Accured Expenses fell 210.38% year-over-year to -$68265.0; the TTM figure through May 2026 stood at -$69415.0 (down 164.97% YoY), while the FY2025 annual figure was $59897.0, down 25.03% from the prior year.
- Change in Accured Expenses declined to -$68265.0 in Q2 2026 per SKYI's latest filing, from -$7443.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $61847.0 in Q2 2025 and bottomed at -$68265.0 in Q2 2026.
- Historically, Change in Accured Expenses has averaged $6500.2 across 3 years, with a median of $6173.0 in 2024.
- Annual changes were most pronounced in 2025 — Change in Accured Expenses soared 1961.57% — and 2026, when it slumped 210.38%.
- Sky Century Investment's Change in Accured Expenses stood at $21910.0 in 2024, then slumped by 57.34% to $9346.0 in 2025, then tumbled by 830.42% to -$68265.0 in 2026.
- Business Quant data shows SKYI's Change in Accured Expenses at -$68265.0 in Q2 2026, -$7443.0 in Q1 2026, and $9346.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 82.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 142.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -219.00 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -4.00 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -8.50 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Sky Century Investment | 393,547.71 | 393,283.71 | 26,045.00 | -68,265.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -68,265.00 |
| May 31, 2026 | -68,265.00 |
| Feb 28, 2026 | -7,443.00 |
| Feb 28, 2026 | -7,443.00 |
| Nov 30, 2025 | 9,346.00 |
| Nov 30, 2025 | 9,346.00 |
| Aug 31, 2025 | -3,053.00 |
| Aug 31, 2025 | -3,053.00 |
| May 31, 2025 | 61,847.00 |
| May 31, 2025 | 61,847.00 |
| Feb 28, 2025 | -20,807.00 |
| Feb 28, 2025 | -20,807.00 |
| Nov 30, 2024 | 21,910.00 |
| Nov 30, 2024 | 21,910.00 |
| Aug 31, 2024 | 43,897.00 |
| Aug 31, 2024 | 43,897.00 |
| May 31, 2024 | 3,000.00 |
| May 31, 2024 | 3,000.00 |
| Feb 29, 2024 | 24,570.00 |
| Feb 29, 2024 | 24,570.00 |